Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

67.52
-0.7700-1.13%
Post-market: 67.520.00000.00%18:30 EDT
Volume:698.16K
Turnover:46.74M
Market Cap:1.47B
PE:-147.97
High:68.40
Open:66.02
Low:65.13
Close:68.29
Loading ...

ANI: Q3 Earnings Snapshot

Associated Press Finance
·
08 Nov 2024

ANI Pharmaceuticals Q3 2024 Adj EPS $1.34 Beats $1.09 Estimate, Sales $148.33M Beat $144.35M Estimate

Benzinga
·
08 Nov 2024

BRIEF-ANI Pharmaceuticals Q3 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.09

Reuters
·
08 Nov 2024

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

THOMSON REUTERS
·
08 Nov 2024

ANI Pharmaceuticals Inc: Outlook FY24 REV $594 Mln - $602 Mln

THOMSON REUTERS
·
08 Nov 2024

ANI Pharmaceuticals Outlook FY Adjusted Ebitda USD 149-153 Million

THOMSON REUTERS
·
08 Nov 2024

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire
·
08 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 Nov 2024

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

GlobeNewswire
·
05 Nov 2024

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

GlobeNewswire
·
31 Oct 2024

Truist Financial Keeps Their Hold Rating on ANI Pharmaceuticals (ANIP)

TIPRANKS
·
28 Oct 2024

ANI Pharmaceuticals Launches Estradiol Gel Following US FDA's Final Approval for Abbreviated New Drug Application

MT Newswires Live
·
25 Oct 2024

ANI Pharmaceuticals announces FDA approval of Estradiol Gel, 0.06%

TIPRANKS
·
25 Oct 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

THOMSON REUTERS
·
25 Oct 2024

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

GlobeNewswire
·
24 Oct 2024

Starboard Slams Pfizer for R&D Inefficiencies, Overpaid Acquisitions

Zacks
·
24 Oct 2024

EDIT Seeks Partner for Reni-Cel Developmental Program, Stock Down

Zacks
·
23 Oct 2024

AstraZeneca Receives CHMP's Approval for Wainzua in Europe

Zacks
·
23 Oct 2024

NVO's Rybelsus Meets Primary Goal in MACE Study for Diabetes Patients

Zacks
·
22 Oct 2024

EDIT Inks Collaboration Deal to Develop Novel Gene Editing Therapies

Zacks
·
22 Oct 2024